PNU 83757
Latest Information Update: 02 Oct 2001
At a glance
- Originator Pharmacia Corporation
- Class
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Erectile dysfunction
Most Recent Events
- 02 Oct 2001 No-Development-Reported for Erectile dysfunction in USA (Unknown route)
- 15 Jun 2000 A study has been added to the adverse events and Men's Health therapeutic trials sections
- 23 May 2000 A study has been added to the Men's Health therapeutic trials, adverse events and pharmacokinetics sections